Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Small Cell Carcinoma in the Head and Neck.

Wakasaki T, Yasumatsu R, Masuda M, Matsuo M, Tamae A, Kubo K, Kogo R, Uchi R, Taura M, Nakagawa T.

Ann Otol Rhinol Laryngol. 2019 Jun 4:3489419853601. doi: 10.1177/0003489419853601. [Epub ahead of print]

PMID:
31161776
2.

Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma.

Wakasaki T, Yasumatsu R, Uchi R, Taura M, Matsuo M, Komune N, Nakagawa T.

Auris Nasus Larynx. 2019 May 22. pii: S0385-8146(18)31048-4. doi: 10.1016/j.anl.2019.05.001. [Epub ahead of print]

PMID:
31128940
3.

A method to measure slice sensitivity profiles of CT images under low-contrast and high-noise conditions.

Goto M, Tominaga C, Taura M, Azumi H, Sato K, Homma N, Mori I.

Phys Med. 2019 Apr;60:100-110. doi: 10.1016/j.ejmp.2019.03.010. Epub 2019 Mar 30.

PMID:
31000069
4.

Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.

Yasumatsu R, Wakasaki T, Hashimoto K, Nakashima K, Manako T, Taura M, Matsuo M, Nakagawa T.

Head Neck. 2019 Aug;41(8):2610-2618. doi: 10.1002/hed.25737. Epub 2019 Mar 5.

PMID:
30835919
5.

The Lupus Susceptibility Locus Sgp3 Encodes the Suppressor of Endogenous Retrovirus Expression SNERV.

Treger RS, Pope SD, Kong Y, Tokuyama M, Taura M, Iwasaki A.

Immunity. 2019 Feb 19;50(2):334-347.e9. doi: 10.1016/j.immuni.2018.12.022. Epub 2019 Jan 29.

PMID:
30709743
6.

Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat.

Taura M, Song E, Ho YC, Iwasaki A.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2282-2289. doi: 10.1073/pnas.1819386116. Epub 2019 Jan 22.

7.

The interaction between IKKα and LC3 promotes type I interferon production through the TLR9-containing LAPosome.

Hayashi K, Taura M, Iwasaki A.

Sci Signal. 2018 May 1;11(528). pii: eaan4144. doi: 10.1126/scisignal.aan4144.

8.

Tilted-wire method for measuring resolution properties of CT images under extremely low-contrast and high-noise conditions.

Tominaga C, Azumi H, Goto M, Taura M, Homma N, Mori I.

Radiol Phys Technol. 2018 Jun;11(2):125-137. doi: 10.1007/s12194-018-0443-8. Epub 2018 Feb 23.

PMID:
29476396
9.

Transcriptional regulation of HIV-1 host factor COMMD1 by the Sp family.

Kudo E, Taura M, Suico MA, Goto H, Kai H, Okada S.

Int J Mol Med. 2018 Apr;41(4):2366-2374. doi: 10.3892/ijmm.2018.3386. Epub 2018 Jan 15.

PMID:
29336469
10.

Squamous cell carcinoma of neck metastasized to the lung and cervical lymph nodes, successfully treated with systemic docetaxel and local radiation therapy to the neck in a renal transplant patient.

Arita T, Asai J, Taura M, Wada M, Takenaka H, Miyashita A, Katoh N.

J Dermatol. 2017 Dec;44(12):e346-e347. doi: 10.1111/1346-8138.14018. Epub 2017 Sep 1. No abstract available.

PMID:
28862322
11.

The treatment and outcome analysis of primary squamous cell carcinoma of the thyroid.

Yasumatsu R, Sato M, Uchi R, Nakano T, Hashimoto K, Kogo R, Taura M, Matsuo M, Nakashima T, Nakagawa T.

Auris Nasus Larynx. 2018 Jun;45(3):553-557. doi: 10.1016/j.anl.2017.07.009. Epub 2017 Jul 22.

PMID:
28739190
12.

Drug eruption caused by esomeprazole: A case report and mini-review.

Taura M, Asai J, Wakabayashi Y, Masuda K, Katoh N.

Allergol Int. 2017 Jul;66(3):499-500. doi: 10.1016/j.alit.2016.12.009. Epub 2017 Jan 13. No abstract available.

13.

Variation of facial features among three African populations: Body height match analyses.

Taura MG, Adamu LH, Gudaji A.

Homo. 2017 Jan;68(1):69-79. doi: 10.1016/j.jchb.2016.12.002. Epub 2016 Dec 13.

PMID:
28017294
14.

Anaphylaxis caused by γ-cyclodextrin in sugammadex.

Hotta E, Tamagawa-Mineoka R, Masuda K, Taura M, Nakagawa Y, Kanehisa F, Tashima S, Katoh N.

Allergol Int. 2016 Jul;65(3):356-8. doi: 10.1016/j.alit.2016.02.013. Epub 2016 Apr 6. No abstract available.

15.

The ETS Factor Myeloid Elf-1-Like Factor (MEF)/Elf4 Is Transcriptionally and Functionally Activated by Hypoxia.

Suico MA, Taura M, Kudo E, Gotoh K, Shuto T, Okada S, Kai H.

Biol Pharm Bull. 2016;39(4):641-7. doi: 10.1248/bpb.b15-00796.

16.

Case of pigmented dermatofibrosarcoma protuberans with atrophic change.

Taura M, Wada M, Kataoka Y, Ueda Y, Takenaka H, Katoh N, Asai J.

J Dermatol. 2016 Oct;43(10):1231-1232. doi: 10.1111/1346-8138.13366. No abstract available.

PMID:
27029004
17.

Drug eruption due to entecavir: A case report and mini-review.

Taura M, Asai J, Cho Z, Wada M, Katoh N.

Allergol Int. 2016 Jul;65(3):334-5. doi: 10.1016/j.alit.2015.12.008. Epub 2016 Jan 23. Review. No abstract available.

18.

Anaphylaxis due to bromovalerylurea.

Taura M, Asai J, Yamazato S, Kanehisa F, Masuda K, Katoh N.

J Dermatol. 2016 Jun;43(6):707-8. doi: 10.1111/1346-8138.13247. Epub 2015 Dec 24. No abstract available.

PMID:
26702871
19.

Study of lip print types among Nigerians.

Adamu LH, Taura MG, Hamman WO, Ojo SA, Dahiru AU, Sadeeq AA, Umar KB.

Homo. 2015 Dec;66(6):561-9. doi: 10.1016/j.jchb.2015.08.002. Epub 2015 Aug 28.

PMID:
26421606
20.

Podocyte p53 Limits the Severity of Experimental Alport Syndrome.

Fukuda R, Suico MA, Kai Y, Omachi K, Motomura K, Koga T, Komohara Y, Koyama K, Yokota T, Taura M, Shuto T, Kai H.

J Am Soc Nephrol. 2016 Jan;27(1):144-57. doi: 10.1681/ASN.2014111109. Epub 2015 May 12.

21.

Case of atrial fibrillation induced by interferon beta treatment for melanoma.

Asai J, Wada M, Ueda Y, Kataoka Y, Taura M, Takenaka H, Katoh N.

J Dermatol. 2015 Jul;42(7):740-1. doi: 10.1111/1346-8138.12874. Epub 2015 Mar 26. No abstract available.

PMID:
25819678
22.

Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases.

Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T, Nunoi H, Sumimoto H.

J Biol Chem. 2015 Mar 6;290(10):6003. doi: 10.1074/jbc.A114.212856. No abstract available.

23.

Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity.

Matsuda K, Hattori S, Kariya R, Komizu Y, Kudo E, Goto H, Taura M, Ueoka R, Kimura S, Okada S.

Biochem Biophys Res Commun. 2015 Feb 13;457(3):288-94. doi: 10.1016/j.bbrc.2014.12.102. Epub 2015 Jan 7.

PMID:
25576356
24.

COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.

Taura M, Kudo E, Kariya R, Goto H, Matsuda K, Hattori S, Vaeteewoottacharn K, McDonald F, Suico MA, Shuto T, Kai H, Okada S.

J Virol. 2015 Mar;89(5):2643-58. doi: 10.1128/JVI.03105-14. Epub 2014 Dec 17.

25.

Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.

Goto H, Kudo E, Kariya R, Taura M, Katano H, Okada S.

J Cancer Res Clin Oncol. 2015 Mar;141(3):465-74. doi: 10.1007/s00432-014-1842-9. Epub 2014 Oct 11.

PMID:
25304617
26.

The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.

Suico MA, Fukuda R, Miyakita R, Koyama K, Taura M, Shuto T, Kai H.

J Biol Chem. 2014 Sep 19;289(38):26143-54. doi: 10.1074/jbc.M114.580209. Epub 2014 Jul 31.

27.

Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.

Goto H, Kojima Y, Matsuda K, Kariya R, Taura M, Kuwahara K, Nagai H, Katano H, Okada S.

Eur J Cancer. 2014 Jul;50(10):1836-1846. doi: 10.1016/j.ejca.2014.03.004. Epub 2014 Apr 9.

PMID:
24726056
28.

Regression equation for estimation of length of humerus from its mophometry in a Nigerian population.

Esomonu UG, Taura MG, Ibeabuchi NM, Modibbo MH.

Nig Q J Hosp Med. 2013 Apr-Jun;23(2):135-8.

PMID:
24579511
29.

Variation in the lobar pattern of the right and left lungs: A case report.

Esomonu UG, Taura MG, Modibbo MH, Egwu AO.

Australas Med J. 2013 Oct 31;6(10):511-4. doi: 10.4066/AMJ.2013.1856. eCollection 2013.

30.

HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.

Kariya R, Taura M, Suzu S, Kai H, Katano H, Okada S.

Cancer Lett. 2014 Jan 1;342(1):52-9. doi: 10.1016/j.canlet.2013.08.045. Epub 2013 Sep 5.

PMID:
24012878
31.

Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.

Srikoon P, Kariya R, Kudo E, Goto H, Vaeteewoottacharn K, Taura M, Wongkham S, Okada S.

Asian Pac J Cancer Prev. 2013;14(7):4441-6.

32.

Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway.

Taura M, Kariya R, Kudo E, Goto H, Iwawaki T, Amano M, Suico MA, Kai H, Mitsuya H, Okada S.

Free Radic Biol Med. 2013 Dec;65:778-788. doi: 10.1016/j.freeradbiomed.2013.08.161. Epub 2013 Aug 20.

PMID:
23973637
33.

Salvage of recurrent hypopharyngeal carcinoma after primary curative treatment.

Yasumatsu R, Nakashima T, Toh S, Taura M, Komune S.

Acta Otolaryngol. 2013 Oct;133(10):1110-6. doi: 10.3109/00016489.2013.815365. Epub 2013 Aug 7.

PMID:
23919670
34.

Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.

Vaeteewoottacharn K, Kariya R, Matsuda K, Taura M, Wongkham C, Wongkham S, Okada S.

J Cancer Res Clin Oncol. 2013 Sep;139(9):1551-62. doi: 10.1007/s00432-013-1473-6. Epub 2013 Jul 23.

PMID:
23877657
35.

Mild electrical stimulation at 0.1-ms pulse width induces p53 protein phosphorylation and G2 arrest in human epithelial cells.

Fukuda R, Suico MA, Koyama K, Omachi K, Kai Y, Matsuyama S, Mitsutake K, Taura M, Morino-Koga S, Shuto T, Kai H.

J Biol Chem. 2013 May 31;288(22):16117-26. doi: 10.1074/jbc.M112.442442. Epub 2013 Apr 18.

36.

Morphological reconstruction of the neoepiglottis after hyo-sub-glosso-epiglottectomy (anteriorly extended supraglottic laryngectomy).

Masuda M, Fukushima J, Kamizono K, Taura M, Uryu H, Fujimura A.

Laryngoscope. 2013 May;123(5):1231-5. doi: 10.1002/lary.23751. Epub 2013 Apr 2. No abstract available.

PMID:
23553338
37.

Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma.

Goto H, Matsuda K, Srikoon P, Kariya R, Hattori S, Taura M, Katano H, Okada S.

Cancer Lett. 2013 May 1;331(2):174-82. doi: 10.1016/j.canlet.2012.12.021. Epub 2013 Jan 12.

PMID:
23321500
38.

Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells.

Kudo E, Taura M, Matsuda K, Shimamoto M, Kariya R, Goto H, Hattori S, Kimura S, Okada S.

Bioorg Med Chem Lett. 2013 Feb 1;23(3):606-9. doi: 10.1016/j.bmcl.2012.12.034. Epub 2012 Dec 21.

PMID:
23290051
39.

STT3B-dependent posttranslational N-glycosylation as a surveillance system for secretory protein.

Sato T, Sako Y, Sho M, Momohara M, Suico MA, Shuto T, Nishitoh H, Okiyoneda T, Kokame K, Kaneko M, Taura M, Miyata M, Chosa K, Koga T, Morino-Koga S, Wada I, Kai H.

Mol Cell. 2012 Jul 13;47(1):99-110. doi: 10.1016/j.molcel.2012.04.015. Epub 2012 May 17.

40.

Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway.

Goto H, Kariya R, Shimamoto M, Kudo E, Taura M, Katano H, Okada S.

Cancer Sci. 2012 Apr;103(4):775-81. doi: 10.1111/j.1349-7006.2012.02212.x. Epub 2012 Feb 21.

41.

Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells.

Taura M, Suico MA, Koyama K, Komatsu K, Miyakita R, Matsumoto C, Kudo E, Kariya R, Goto H, Kitajima S, Takahashi C, Shuto T, Nakao M, Okada S, Kai H.

Mol Cell Biol. 2012 Apr;32(8):1581-90. doi: 10.1128/MCB.06454-11. Epub 2012 Feb 6.

42.

Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-κB pathway.

Matsuno T, Kariya R, Yano S, Morino-Koga S, Taura M, Suico MA, Shimauchi Y, Matsuyama S, Okamoto Y, Shuto T, Kai H, Okada S.

Int J Oncol. 2012 Apr;40(4):1071-8. doi: 10.3892/ijo.2011.1313. Epub 2011 Dec 20.

43.

Physician-received scatter radiation with angiography systems used for interventional radiology: comparison among many X-ray systems.

Chida K, Morishima Y, Inaba Y, Taura M, Ebata A, Takeda K, Shimura H, Zuguchi M.

Radiat Prot Dosimetry. 2012 May;149(4):410-6. doi: 10.1093/rpd/ncr312. Epub 2011 Nov 23.

PMID:
22117021
44.

Comparison of dose at an interventional reference point between the displayed estimated value and measured value.

Chida K, Inaba Y, Morishima Y, Taura M, Ebata A, Yanagawa I, Takeda K, Zuguchi M.

Radiol Phys Technol. 2011 Jul;4(2):189-93. doi: 10.1007/s12194-011-0121-6. Epub 2011 Jun 4.

PMID:
21643656
45.

Internal jugular vein reconstruction: application of conventional type A and novel type K methods.

Kamizono K, Ejima M, Taura M, Masuda M.

J Laryngol Otol. 2011 Jun;125(6):643-8. doi: 10.1017/S0022215110003038. Epub 2011 Apr 1.

PMID:
21457591
46.

Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice.

Ono A, Hattori S, Kariya R, Iwanaga S, Taura M, Harada H, Suzu S, Okada S.

J Biomed Biotechnol. 2011;2011:539748. doi: 10.1155/2011/539748. Epub 2011 Jan 26.

47.

Mandible preserving pull-through oropharyngectomy for advanced oropharyngeal cancer: a pilot study.

Masuda M, Fukushima J, Kadota H, Kamizono K, Ejima M, Taura M.

Auris Nasus Larynx. 2011 Jun;38(3):392-7. doi: 10.1016/j.anl.2010.08.010. Epub 2010 Oct 25.

PMID:
20980111
48.

Endoplasmic reticulum stress increases the expression and function of toll-like receptor-2 in epithelial cells.

Shimasaki S, Koga T, Shuto T, Suico MA, Sato T, Watanabe K, Morino-Koga S, Taura M, Okada S, Mori K, Kai H.

Biochem Biophys Res Commun. 2010 Nov 12;402(2):235-40. doi: 10.1016/j.bbrc.2010.09.132. Epub 2010 Oct 8.

PMID:
20933500
49.

Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.

Ota K, Fujimori H, Ueda M, Jono H, Shinriki S, Ota T, Sueyoshi T, Taura M, Taguma A, Kai H, Shinohara M, Ando Y.

Int J Oncol. 2010 Oct;37(4):797-804.

PMID:
20811700
50.

MEF/ELF4 transactivation by E2F1 is inhibited by p53.

Taura M, Suico MA, Fukuda R, Koga T, Shuto T, Sato T, Morino-Koga S, Okada S, Kai H.

Nucleic Acids Res. 2011 Jan;39(1):76-88. doi: 10.1093/nar/gkq762. Epub 2010 Aug 30.

Supplemental Content

Support Center